Health giant GlaxoSmithKline (GSK), whose brands include Tums and Sensodyne, has chosen Omnicom’s PHD and Medicom to handle its global media account moving forward.
The appointments come after GSK chose to review its media business earlier this year after combining forces with drug maker Novartis through a joint venture in March.
A spokeperson at GSK said: "The comprehensive review of our media agency partnerships has determined GroupM (MediaCom and Mindshare) and PHD are each best positioned in unique ways to partner with GSK in achieving our growth ambitions. Both are world class global media agencies and will be key partners in driving media strategy and trading for the new GSK and we are delighted to make these awards."
Starcom previously handled media for Novartis but decided not to participate in the most recent review, while GSK split its account between WPP’s GroupM and Omnicom.
The consumer healthcare business is one of many global advertisers to review its media over the past year.